ORBIMED ADVISORS LLC Insider Trading $CRVS Corvus Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ORBIMED ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in GLAUKOS Corp ($GKOS) and Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and in ACCELERON PHARMA INC ($XLRN) and Director in ProNAi Therapeutics Inc ($DNAI) and 10% Owner in AVEDRO INC ($AVDR) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Aerpio Pharmaceuticals, Inc. ($ARPO) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in SI-BONE, Inc. ($SIBN) and Director in Xtant Medical Holdings, Inc. ($XTNT) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Roka BioScience, Inc. ($ROKA) and 10% Owner in Kala Pharmaceuticals, Inc. ($KALA) and Director in Otonomy, Inc. ($OTIC) and 10% Owner in Arsanis, Inc. ($ASNS) and 10% Owner in Principia Biopharma Inc. ($PRNB) and Director in Acutus Medical, Inc. ($AFIB) and Director in SYNLOGIC, INC. ($MIRN) and 10% Owner in NeuroPace Inc ($NPCE) and 10% Owner in GRAYBUG VISION, INC. ($GRAY) and 10% Owner in Sientra, Inc. ($SIEN) and 10% Owner in TELA Bio, Inc. ($TELA) and Director in Loxo Oncology, Inc. ($LOXO) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in PIERIS PHARMACEUTICALS, INC. ($PIRS) and Director in Dimension Therapeutics, Inc. ($DMTX) and 10% Owner in Guardant Health, Inc. ($GH) and 10% Owner in ViewRay, Inc. ($VRAY) and Director in ViewRay, Inc. ($VRAY) and Director in Turning Point Therapeutics, Inc. ($TPTX) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and 10% Owner in Inspire Medical Systems, Inc. ($INSP) and Director in Inspire Medical Systems, Inc. ($INSP) and Director in Synthorx, Inc. ($THOR) and 10% Owner in scPharmaceuticals Inc. ($SCPH) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and Director in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in Aeglea BioTherapeutics, Inc. ($AGLE) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in Intellia Therapeutics, Inc. ($NTLA) and 10% Owner in Alector, Inc. ($ALEC) and Director in Alector, Inc. ($ALEC) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in NextCure, Inc. ($NXTC) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in IMARA Inc. ($IMRA) and Director in Keros Therapeutics, Inc. ($KROS) and Director in Prelude Therapeutics Inc ($PRLD) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in resTORbio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and 10% Owner in SpringWorks Therapeutics, Inc. ($SWTX) and Director in Edgewise Therapeutics, Inc. ($EWTX) and Director in 89bio, Inc. ($ETNB) and Director in Arcutis Biotherapeutics, Inc. ($ARQT) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Fusion Pharmaceuticals Inc. ($FUSN) and Director in Terns Pharmaceuticals, Inc. ($TERN) and Director in Ikena Oncology, Inc. ($IKNA).

Over the past year ORBIMED ADVISORS LLC has been an insider in 17 companies. The total value of shares held by ORBIMED ADVISORS LLC in these companies amounts to $185,877,774.

ORBIMED ADVISORS LLC Director
89bio, Inc.
ACCELERON PHARMA INC
Director
Acutus Medical, Inc.
Director
Adaptimmune Therapeutics PLC
Director
Adicet Bio, Inc.
10% Owner
Aeglea BioTherapeutics, Inc.
10% Owner, Director
Aerpio Pharmaceuticals, Inc.
10% Owner, Director
Alector, Inc.
Director
ALPINE IMMUNE SCIENCES, INC.
Director
Arcutis Biotherapeutics, Inc.
Director
ARMO BioSciences, Inc.
10% Owner, Director
Audentes Therapeutics, Inc.
10% Owner
AVEDRO INC
10% Owner
CONSTELLATION PHARMACEUTICALS INC
Director
Corvus Pharmaceuticals, Inc.
10% Owner
CTI BIOPHARMA CORP
Director
Decibel Therapeutics, Inc.
Director
Dimension Therapeutics, Inc.
Director
Edgewise Therapeutics, Inc.
Director
Fusion Pharmaceuticals Inc.
Director
GLAUKOS Corp
10% Owner
GRAYBUG VISION, INC.
10% Owner
Guardant Health, Inc.
Director
Ikena Oncology, Inc.
Director
IMARA Inc.
Director, 10% Owner
Inspire Medical Systems, Inc.
Director
Intellia Therapeutics, Inc.
Director
INTERCEPT PHARMACEUTICALS, INC.
10% Owner
Kala Pharmaceuticals, Inc.
Director
Keros Therapeutics, Inc.
Kinnate Biopharma Inc.
Director
LogicBio Therapeutics, Inc.
Director
Loxo Oncology, Inc.
10% Owner
NeuroPace Inc
Director
NextCure, Inc.
Director
Oric Pharmaceuticals, Inc.
Director
OTONOMY, INC.
10% Owner, Director
PIERIS PHARMACEUTICALS, INC.
Director
PMV Pharmaceuticals, Inc.
Director
Prelude Therapeutics Inc
Director
Prevail Therapeutics Inc.
10% Owner
Principia Biopharma Inc.
10% Owner
Relypsa Inc
Director
Repare Therapeutics Inc.
Director
RESPONSE BIOMEDICAL CORP
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
scPharmaceuticals Inc.
Director
SELECTA BIOSCIENCES INC
Director
SI-BONE, Inc.
10% Owner
Sientra, Inc.
Director
Sierra Oncology, Inc.
Director
Silverback Therapeutics, Inc.
10% Owner, Director
Sorrento Tech, Inc.
10% Owner
SpringWorks Therapeutics, Inc.
10% Owner
SteadyMed Ltd.
Director
SYNLOGIC, INC.
Director
Synthorx, Inc.
10% Owner
TELA Bio, Inc.
Director
Terns Pharmaceuticals, Inc.
Director
Tricida, Inc.
Director
Turning Point Therapeutics, Inc.
10% Owner, Director
ViewRay, Inc.
10% Owner
X4 Pharmaceuticals, Inc
Director
Xtant Medical Holdings, Inc.
$ 185877774 The total value of shares held by ORBIMED ADVISORS LLC
Insider Rank

ORBIMED ADVISORS LLC ranks 240 out of 350,000 insiders. Go to Insider Ranking to see more.

ORBIMED ADVISORS LLC in Corvus Pharmaceuticals, Inc.

Trading Symbol: CRVS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: Director
Holdings: 8,053,298 shares
Current Value: $111,377,111
Latest Transaction: Feb 19 2021
$CRVS Market Capitalization: $293.59M
$CRVS Previous Close: $13.83

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 22x
Sell: 0x
Shares Bought: 8,053,298
Shares Sold: 0
Share Difference: +8,053,298
Value Difference: -$22,233,827

Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Corvus Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000011
Value of Purchases ($)000004,499,9994,499,999
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, XLRN, AFIB, ADAP, TORC, AGLE, ARPO, ALEC, ALPN, ARQT, ARMO, BOLD, AVDR, CNST, CRVS, CTIC, DBTX, DMTX, EWTX, FUSN, GKOS, GRAY, GH, IKNA, IMRA, INSP, NTLA, ICPT, KALA, KROS, KNTE, LOGC, LOXO, NPCE, NXTC, ORIC, OTIC, PIRS, PMVP, PRLD, PRVL, PRNB, RLYP, RPTX, RPBIF, RYTM, SCPH, SELB, SIBN, SIEN, SRRA, SBTX, ROKA, SWTX, STDY, SYBX, THOR, TELA, TERN, TCDA, TPTX, VRAY, ASNS, XTNT

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 19 2021CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP3.501,285,7144,499,9998,053,2986.8 M to 8.1 M (+19.00 %)
Aug 08 2019CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP3.51142,656500,7236,767,5846.6 M to 6.8 M (+2.15 %)
Jul 01 2019CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP3.9159,243231,6406,624,9286.6 M to 6.6 M (+0.90 %)
Jul 01 2019CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP3.72565,1782,102,4626,565,6856 M to 6.6 M (+9.42 %)
Jul 01 2019CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP3.3432,923109,9636,000,5076 M to 6 M (+0.55 %)
Mar 14 2018CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP8.50588,2354,999,9985,967,5845.4 M to 6 M (+10.94 %)
Jun 27 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.9990011,6915,379,3495.4 M to 5.4 M (+0.02 %)
Jun 27 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.921001,2925,378,4495.4 M to 5.4 M (0.00 %)
Jun 21 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.8726,083335,6885,378,3495.4 M to 5.4 M (+0.49 %)
Jun 21 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.4812,300153,5045,352,2665.3 M to 5.4 M (+0.23 %)
Jun 16 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.045,00060,2005,339,9665.3 M to 5.3 M (+0.09 %)
Jun 16 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP11.945,00059,7005,334,9665.3 M to 5.3 M (+0.09 %)
Jun 16 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.7110,000127,1005,329,9665.3 M to 5.3 M (+0.19 %)
Jun 13 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.9820,000259,6005,319,9665.3 M to 5.3 M (+0.38 %)
Jun 13 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.9530,000388,5005,299,9665.3 M to 5.3 M (+0.57 %)
May 24 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP13.094,71661,7325,269,9665.3 M to 5.3 M (+0.09 %)
May 20 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.75617785,265,2505.3 M to 5.3 M (0.00 %)
May 20 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP12.112,53930,7475,265,1895.3 M to 5.3 M (+0.05 %)
May 20 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP11.554,20048,5105,262,6505.3 M to 5.3 M (+0.08 %)
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.00713,77600
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorOption ExerciseC0.003,994,67400
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyP15.00550,0008,250,0005,258,4504.7 M to 5.3 M (+11.68 %)
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyC0.00713,77604,708,4504 M to 4.7 M (+17.87 %)
Mar 29 2016CRVSCorvus Pharmaceuti ...ORBIMED ADVISORS LLCDirectorBuyC0.003,994,67403,994,6740 to 4 M

Page:   1